Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Palak Trivedi

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Immunotherapy|December 14, 2011
Conference scene: Recent advancements in immunotherapyPalak Trivedi
Current Opinion in Pharmacology|December 11, 2021
Emerging drugs for the treatment of primary sclerosing cholangitisNadir Abbas, Mohammad Nabil Quraishi, Palak Trivedi
World Journal of Gastroenterology|March 18, 2009
Intraductal papillary mucinous neoplasm in chronic calcifying pancreatitis: egg or hen?Evangelos Kalaitzakis, Barbara Braden, Palak Trivedi, et al.
British Journal of Hospital Medicine (London, England : 2005)|October 8, 2019
Challenges in the use of corticosteroids in the management of autoimmune hepatitisRoger W Chapman, Richard J Aspinall, Palak Trivedi, et al.
JHEP Reports : Innovation in Hepatology|July 9, 2024
Erratum to "Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis" [JHEP Reports 6 (2024) 100949]Patrick McKiernan, Jesus Quintero Bernabeu, Muriel Girard, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2026
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary CholangitisJörn M Schattenberg, Jesus M Banales, Gideon Hirschfield, et al.
BMJ Open Gastroenterology|March 3, 2025
Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot studyAmera Elzubeir, Juliet High, Matthew Hammond, et al.
BMJ Open Gastroenterology|December 11, 2025
Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort studyUsha Gungabissoon, Jake Hunnicutt, Eleanor J McDermott, et al.
Hepatology (Baltimore, Md.)|December 5, 2025
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severityNasir Hussain, Rodrigo V Motta, Usha Gungabissoon, et al.
BMC Gastroenterology|March 16, 2023
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitisMichael Trauner, Chuhan Chung, Kate Sterling, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Immunotherapy|December 14, 2011
Conference scene: Recent advancements in immunotherapyPalak Trivedi
Current Opinion in Pharmacology|December 11, 2021
Emerging drugs for the treatment of primary sclerosing cholangitisNadir Abbas, Mohammad Nabil Quraishi, Palak Trivedi
World Journal of Gastroenterology|March 18, 2009
Intraductal papillary mucinous neoplasm in chronic calcifying pancreatitis: egg or hen?Evangelos Kalaitzakis, Barbara Braden, Palak Trivedi, et al.
British Journal of Hospital Medicine (London, England : 2005)|October 8, 2019
Challenges in the use of corticosteroids in the management of autoimmune hepatitisRoger W Chapman, Richard J Aspinall, Palak Trivedi, et al.
JHEP Reports : Innovation in Hepatology|July 9, 2024
Erratum to "Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis" [JHEP Reports 6 (2024) 100949]Patrick McKiernan, Jesus Quintero Bernabeu, Muriel Girard, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2026
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary CholangitisJörn M Schattenberg, Jesus M Banales, Gideon Hirschfield, et al.
BMJ Open Gastroenterology|March 3, 2025
Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot studyAmera Elzubeir, Juliet High, Matthew Hammond, et al.
BMJ Open Gastroenterology|December 11, 2025
Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort studyUsha Gungabissoon, Jake Hunnicutt, Eleanor J McDermott, et al.
Hepatology (Baltimore, Md.)|December 5, 2025
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severityNasir Hussain, Rodrigo V Motta, Usha Gungabissoon, et al.
BMC Gastroenterology|March 16, 2023
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitisMichael Trauner, Chuhan Chung, Kate Sterling, et al.
Pageof 3